Association of HIV-1 viral phenotype in the MT-2 assay with perinatal hiv transmission

Journal of Acquired Immune Deficiency Syndromes

Volumn 30, Issue 1, 2002, Pages 88-94

  LaRussa, Philip ^a   Magder, Laurence S ^a   Pitt, Jane ^a   Sill, Anne ^a   Hillyer, George ^a   Hollinger, F Blaine ^a   Lew, Judy ^a   McIntosh, Kenneth ^a   Kufera, Joseph ^a   Bremer, Jim ^a   Blattner, William ^a   Diaz, Clemente ^a   Pacheco Acosta, Edna ^a   Tuomala, Ruth ^a   Cooper, Ellen ^a   Mesthene, Donna ^a   Higgins, Alice ^a   Landesman, Sheldon ^a   Handelsman, Edward ^a   Moroso, Gail ^a   Rich, Kenneth ^a   Turpin, Delmyra ^a   Shearer, William ^a   Pacheco, Susan ^a   Cooper, Norma ^a   Adeniyi Jones, Samuel ^a   Matzen, Elaine ^a   Nugent, Robert ^a   Smeriglio, Vincent ^a   Davenny, Katherine ^a   Thompson, Bruce ^a   more..

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

HIV 1; Perinatal transmission; Viral phenotype

Indexed keywords

CD4 ANTIGEN; ZIDOVUDINE;

ADULT; ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PERINATAL INFECTION; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; STATISTICAL MODEL; VERTICAL TRANSMISSION; VIRUS GENE; VIRUS ISOLATION; VIRUS TRANSMISSION;

EID: 18344372014     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200205010-00012     Document Type: Article

References (33)

1. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: Frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex
2. Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual
3. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations
4. A novel in vitro HIV property in pediatric isolates
5. HIV-1 biologic phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment
6. Vertical transmission of HIV-1: Lack of detectable virus in peripheral blood cells of infected children at birth
7. Patterns of antibody response against the V3 loop in children with vertically acquired immunodeficiency virus type I (HIV-1)
8. Syncytia formation and HIV load
9. Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS
10. Zidovudine resistance, syncytium-inducing phenotype, and HIV disease progression in a case-control study
11. Development of resistance of zidovudine (ZDV) and didanosine (ddI) in HIV from patients in ZDV, ddI and alternating ZDV/ddI therapy
12. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child
13. Neutralizing antibodies and viral characteristics in mother-to-child transmission of HIV-1
14. Transmission of human immunodeficiency virus type I (HIV-1) from mother to child correlates with viral phenotype
15. Biological phenotypes of HIV-1 in pathogenesis and transmission
16. The role of virologic and immunologic factors in mother-to-child transmission of HIV-1
17. The role of timing of HIV maternal-fetal transmission (in utero vs. intrapartum) and HIV phenotype on onset of symptoms in vertically infected infants
18. Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission
19. Vertical transmission of human immunodeficiency virus type 1: Autologous neutralizing antibody, virus load, and virus phenotype
20. Viral phenotype in mother-to-child HIV-1 transmission and disease progression of vertically acquired HIV-1 infection
21. Human cord blood mononuclear cells are preferentially infected by non-syncytium-inducing, macrophage-tropic human immunodeficiency virus type I isolates
22. Clinical significance of human immunodeficiency virus type I phenotypes in infected children
23. Maternal HIV-1 viral load and vertical transmission of infection: The Ariel Project for the prevention of HIV transmission from mother to infant
24. Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro
25. 3′-Azido-3′-deoxythymidine-induced reduction in the ability of uninfected CD4-expressing cells to participate in syncytium formation
26. AZT/ddIcombination therapy inhibits both SI and NSI HIV-1 variants
27. In vivo inhibition of syncytium-inducing variants of HIV in patients treated with didanosine
28. CC CKR5: A RANTES, MIP-1alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1
29. Identification of a major coreceptor for primary isolates of HIV-1
30. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
31. A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants